Body Mass Index and Prognostic Nutritional Index as Indicators of Treatment Adherence and Survival Outcomes in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Undergoing Sequential Chemoradiotherapy - Takeaways - MDSpire

Body Mass Index and Prognostic Nutritional Index as Indicators of Treatment Adherence and Survival Outcomes in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Undergoing Sequential Chemoradiotherapy

  • By

  • Esra Zeynelgil

  • Engin Eren Kavak

  • İsmail Dilli

  • Özlem Aydın İsak

  • Doğan Yazılıtaş

  • Gökşen İnanç İmamoğlu

  • Ömer Bayır

  • December 15, 2025

  • 0 min

Share

  • 1

    Head and neck cancers account for 5-6% of male cancers in the U.S., with squamous cell carcinoma being the most prevalent type.

  • 2

    Induction chemotherapy followed by concurrent chemoradiotherapy may enhance treatment efficacy and organ function preservation in advanced HNSCC.

  • 3

    Toxicity from treatment can lead to decreased quality of life, treatment failure, and reduced survival in patients with HNSCC.

  • 4

    The study evaluates Body Mass Index (BMI) and Prognostic Nutritional Index (PNI) as predictors of treatment adherence and survival outcomes.

  • 5

    Statistical analyses were conducted using SPSS, with survival assessed via Kaplan-Meier and factors influencing treatment response analyzed through logistic regression.

Original Source(s)

Related Content